MBX Biosciences Inc’s filing revealed that its Director Pescovitz Ora H. acquired Company’s shares for reported $45312.0 on Apr 08 ’25. In the deal valued at $5.89 per share,7,693 shares were bought. As a result of this transaction, Pescovitz Ora H. now holds 24,329 shares worth roughly $0.25 million.
Then, GORDON CARL L bought 143,170 shares, generating $1,551,963 in total proceeds. Upon buying the shares at $10.84, the Director now owns 3,255,000 shares.
Before that, GORDON CARL L bought 47,502 shares. MBX Biosciences Inc shares valued at $468,793 were divested by the Director at a price of $9.87 per share. As a result of the transaction, GORDON CARL L now holds 3,205,930 shares, worth roughly $32.38 million.
Citizens JMP initiated its MBX Biosciences Inc [MBX] rating to a Mkt outperform in a research note published on April 10, 2025; the price target was $38. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early October with a ‘”a Buy”‘ rating. JP Morgan began covering MBX with “an Overweight” recommendation on October 08, 2024. Jefferies started covering the stock on October 08, 2024. It rated MBX as “a Buy”.
Price Performance Review of MBX
On Tuesday, MBX Biosciences Inc [NASDAQ:MBX] saw its stock fall -3.81% to $10.10. Over the last five days, the stock has lost -11.83%. MBX Biosciences Inc shares have fallen nearly -45.20% since the year began.
Levels Of Support And Resistance For MBX Stock
The 24-hour chart illustrates a support level at 9.71, which if violated will result in even more drops to 9.32. On the upside, there is a resistance level at 10.83. A further resistance level may holdings at 11.56.
The most recent change occurred on October 08, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $44 price target.
